Prognostic Factors of Castration-Resistant Prostate Cancer Among Patients With Localized Prostate Cancer Who Underwent Robot-Assisted Radical Prostatectomy in a Retrospective Multicenter Japanese Cohort (MSUG94). [PDF]
Sasaki T +18 more
europepmc +1 more source
Phase 2 trial of pTVG-HP ± pTVG-AR DNA vaccines and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC). [PDF]
Kyriakopoulos CE +5 more
europepmc +1 more source
Two Cases of Metastatic Castration-Resistant Prostate Cancer With Long-Term Survival Treated With Abiraterone. [PDF]
Une M +5 more
europepmc +1 more source
Combined [ 223 Ra]Radiumdichloride and [ 177 Lu]Lu-PSMA-617 Therapy in End-stage Metastatic Castration-resistant Prostate Cancer. [PDF]
Hügle MJ +4 more
europepmc +1 more source
TLN1 interacts with NGFR and suppresses the development of castration-resistant prostate cancer by upregulating NGFR. [PDF]
Li S +7 more
europepmc +1 more source
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort. [PDF]
Wenzel M +12 more
europepmc +1 more source
Oligometastatic Prostate Cancer: Clues from an N-of-1. [PDF]
Kirschenbaum A +7 more
europepmc +1 more source
Metastasis of Castration-Resistant Prostate Adenocarcinoma to the Lacrimal Gland: A Case Report. [PDF]
Milic N +4 more
europepmc +1 more source
The Role of Gut Microbiome in Prostate Cancer: Current Evidence and Emerging Opportunities. [PDF]
Huang J, Zhu XH, Trotman LC, Tsao CK.
europepmc +1 more source

